TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISORDERS
4.2.2 INCREASING SPENDING IN MEDICAL RESEARCH
4.3 RESTRAINT
4.3.1 CONCERNS PERTAINING TO THE EFFICIENCY AND ACCURACY OF TEST KITS
4.4 OPPORTUNITY
4.4.1 EMERGENCE OF AUTOMATED BLOOD GROUPING DEVICES
4.5 TECHNOLOGICAL DISRUPTION
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D AND DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES REVIEW
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF BUYERS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19
5.3.1 IMPACT ON DEMAND
5.3.2 IMPACT ON SUPPLY CHAIN
5.4 VOLUME OF TESTS FOR DONATED BLOOD, BY REGION, 2020
5.5 BLOOD TRANSFUSION VOLUME, BY REGION, 2020
6 GLOBAL BLOOD GROUPING REAGENTS, BY PRODUCT
6.1 OVERVIEW
6.2 CONSUMABLES
6.3 INSTRUMENTS
6.3.1 FULLY-AUTOMATED INSTRUMENTS
6.3.2 SEMI-AUTOMATED INSTRUMENTS
7 GLOBAL BLOOD GROUPING REAGENTS, BY TECHNIQUE
7.1 OVERVIEW
7.2 PCR-BASED AND MICROARRAY TECHNIQUE
7.3 ASSAY-BASED TECHNIQUES
7.4 MASSIVELY PARALLEL SEQUENCING TECHNIQUES
7.5 SEROLOGY
7.5.1 GEL TECHNIQUE
7.5.2 EMT
7.5.3 SPRCA
7.5.4 GLASS SLIDE AND TUBES
7.5.5 CASSETTE/KIT
7.5.6 OTHER SEROLOGY
7.6 OTHER TECHNIQUES
8 GLOBAL BLOOD GROUPING REAGENTS, BY TEST TYPE
8.1 OVERVIEW
8.2 BLOOD GROUP AND PHENOTYPES
8.3 ANTIBODY SCREENING
8.4 CROSSMATCHING TESTS
8.5 ANTIBODY IDENTIFICATION
8.6 COOMBS TEST
8.7 ANTIGEN TYPING
9 GLOBAL BLOOD GROUPING REAGENTS, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 BLOOD BANKS
9.4 CLINICAL LABORATORIES
10 GLOBAL BLOOD GROUPING REAGENTS MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 SPAIN
10.3.5 ITALY
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 COMPETITIVE OVERVIEW
11.2 MAJOR PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET
11.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET
11.4 COMPETITIVE BENCHMARKING
11.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES
11.6.2 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS
11.7 MAJOR PLAYERS FINANCIAL MATRIX
11.7.1 REVENUE OF MAJOR PLAYERS, 2020
11.7.2 R&D EXPENDITURE
12 COMPANY PROFILES
12.1 MERCK KGAA
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 BIO-RAD LABORATORIES, INC.
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 NOVACYT GROUP
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 KEY STRATEGIES
12.4 BECKMAN COULTER, INC.
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 KEY STRATEGIES
12.5 HAEMOKINESIS PTY LTD
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 KEY STRATEGIES
12.6 MTC MED. PRODUKTE GMBH
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS/SERVICES OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 DAY MEDICAL SA
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 RAPID LABS LTD
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 KEY STRATEGIES
12.9 ORTHO CLINICAL DIAGNOSTICS
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 DIAGAST SAS
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
12.11 GRIFOLS SA
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL OVERVIEW
12.11.3 PRODUCTS/SERVICES OFFERED
12.11.4 KEY DEVELOPMENTS
12.11.5 SWOT ANALYSIS
12.11.6 KEY STRATEGIES
12.12 IMMUCOR, INC.
12.12.1 COMPANY OVERVIEW
12.12.2 FINANCIAL OVERVIEW
12.12.3 PRODUCTS/SERVICES OFFERED
12.12.4 KEY DEVELOPMENTS
12.12.5 SWOT ANALYSIS
12.12.6 KEY STRATEGIES
12.13 QUOTIENT LTD
12.13.1 COMPANY OVERVIEWS
12.13.2 FINANCIAL OVERVIEW
12.13.3 PRODUCTS/SERVICES OFFERED
12.13.4 KEY DEVELOPMENTS
12.13.5 SWOT ANALYSIS
12.13.6 KEY STRATEGIES
12.14 YUVRAJ BIOBIZ INCUBATOR INDIA PVT LTD
12.14.1 COMPANY OVERVIEW
12.14.2 FINANCIAL OVERVIEW
12.14.3 PRODUCTS/SERVICES OFFERED
12.14.4 KEY DEVELOPMENTS
12.14.5 KEY STRATEGIES
12.15 TULIP DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 FINANCIAL OVERVIEW
12.15.3 PRODUCTS/SERVICES OFFERED
12.15.4 KEY DEVELOPMENTS
12.15.5 KEY STRATEGIES
12.16 AIKANG
12.16.1 COMPANY OVERVIEW
12.16.2 FINANCIAL OVERVIEW
12.16.3 PRODUCTS/SERVICES OFFERED
12.16.4 KEY DEVELOPMENTS
12.16.5 KEY STRATEGIES
12.17 INTEC
12.17.1 COMPANY OVERVIEW
12.17.2 FINANCIAL OVERVIEW
12.17.3 PRODUCTS OFFERED
12.17.4 KEY DEVELOPMENTS
12.17.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 PREVALENCE OF TRANSFUSION-TRANSMISSIBLE INFECTIONS IN BLOOD DONATIONS (MEDIAN, INTERQUARTILE RANGE (IQR)), BY INCOME GROUPS
TABLE 4 AVERAGE VOLUME OF TESTS, BY REGION (MILLION)
TABLE 5 AVERAGE BLOOD TRANSFUSION VOLUME, BY REGION (MILLION UNITS)
TABLE 6 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
TABLE 7 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR CONSUMABLES, BY REGION, 2022–2030 (USD MILLION)
TABLE 8 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR INSTRUMENTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 9 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 10 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR FULLY-AUTOMATED, BY REGION, 2022–2030 (USD MILLION)
TABLE 11 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR SEMI-AUTOMATED, BY REGION, 2022–2030 (USD MILLION)
TABLE 12 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
TABLE 13 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR PCR-BASED AND MICROARRAY TECHNIQUE, BY REGION, 2022–2030 (USD MILLION)
TABLE 14 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ASSAY-BASED TECHNIQUES, BY REGION, 2022–2030 (USD MILLION)
TABLE 15 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR MASSIVELY PARALLEL SEQUENCING TECHNIQUES, BY REGION, 2022–2030 (USD MILLION)
TABLE 16 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR SEROLOGY, BY REGION, 2022–2030 (USD MILLION)
TABLE 17 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR SEROLOGY, BY TYPE, 2022–2030 (USD MILLION)
TABLE 18 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR GEL TECHNIQUE, BY REGION, 2022–2030 (USD MILLION)
TABLE 19 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR EMT, BY REGION, 2022–2030 (USD MILLION)
TABLE 20 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR SPRCA, BY REGION, 2022–2030 (USD MILLION)
TABLE 21 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR GLASS SLIDE AND TUBES, BY REGION, 2022–2030 (USD MILLION)
TABLE 22 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR CASSETTE/KIT, BY REGION, 2022–2030 (USD MILLION)
TABLE 23 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR OTHER SEROLOGY, BY REGION, 2022–2030 (USD MILLION)
TABLE 24 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR OTHER TECHNIQUES, BY REGION, 2022–2030 (USD MILLION)
TABLE 25 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 26 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR BLOOD GROUP AND PHENOTYPE, BY REGION, 2022–2030 (USD MILLION)
TABLE 27 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ANTIBODY SCREENING, BY REGION, 2022–2030 (USD MILLION)
TABLE 28 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR CROSS-MATCHING TESTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 29 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ANTIBODY IDENTIFICATION, BY REGION, 2022–2030 (USD MILLION)
TABLE 30 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR COOMBS TESTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 31 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ANTIGEN TYPING, BY REGION, 2022–2030 (USD MILLION)
TABLE 32 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 33 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
TABLE 34 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR BLOOD BANKS, BY REGION, 2022–2030 (USD MILLION)
TABLE 35 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR CLINICAL LABORATORIES, BY REGION, 2022–2030 (USD MILLION)
TABLE 36 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 37 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 38 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 39 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 40 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 41 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 42 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 43 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 44 US: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 45 US: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 46 US: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 47 US: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 48 US: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 49 US: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 50 CANADA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 51 CANADA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 52 CANADA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 53 CANADA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 54 CANADA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 55 CANADA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 56 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 57 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 58 EUROPE: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 59 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 60 EUROPE: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 61 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 62 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 63 GERMANY: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 64 GERMANY: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 65 GERMANY: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 66 GERMANY: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 67 GERMANY: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 68 GERMANY: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 69 UK: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 70 UK: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 71 UK: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 72 UK: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 73 UK: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 74 UK: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 75 FRANCE: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 76 FRANCE: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 77 FRANCE: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 78 FRANCE: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 79 FRANCE: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 80 FRANCE: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 81 SPAIN: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 82 SPAIN: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 83 SPAIN: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 84 SPAIN: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 85 SPAIN: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 86 SPAIN: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 87 ITALY: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 88 ITALY: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 89 ITALY: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 90 ITALY: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 91 ITALY: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 92 ITALY: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 93 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 94 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 95 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 96 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 97 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 98 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 99 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 100 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 101 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 102 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 103 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 104 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 105 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 106 CHINA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 107 CHINA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 108 CHINA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 109 CHINA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 110 CHINA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 111 CHINA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 112 JAPAN: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 113 JAPAN: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 114 JAPAN: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 115 JAPAN: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 116 JAPAN: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 117 JAPAN: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 118 INDIA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 119 INDIA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 120 INDIA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 121 INDIA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 122 INDIA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 123 INDIA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 124 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 125 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 126 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 127 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 128 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 129 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 130 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 131 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 132 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 133 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 134 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 135 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 136 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 137 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 138 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 139 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 140 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 141 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 142 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 143 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 144 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 145 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 146 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 147 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 148 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 149 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 150 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 151 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 152 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 153 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 154 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 155 AFRICA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 156 AFRICA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 157 AFRICA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 158 AFRICA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 159 AFRICA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 160 AFRICA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 161 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 162 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 163 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 164 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
TABLE 165 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
TABLE 166 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 167 MAJOR PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET
TABLE 168 THE MOST ACTIVE PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET
TABLE 169 NEW PRODUCT DEVELOPMENTS/LAUNCHES
TABLE 170 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS
TABLE 171 MERCK KGAA: PRODUCTS OFFERED
TABLE 172 MERCK KGAA: KEY DEVELOPMENTS
TABLE 173 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 174 NOVACYT GROUP: PRODUCTS/SERVICES OFFERED
TABLE 175 BECKMAN COULTER, INC.: PRODUCTS OFFERED
TABLE 176 BECKMAN COULTER, INC.: KEY DEVELOPMENTS
TABLE 177 HAEMOKINESIS PTY LTD: PRODUCTS OFFERED
TABLE 178 MTC MED. PRODUKTE GMBH: PRODUCTS/TECHNOLOGIES OFFERED
TABLE 179 DAY MEDICAL SA: PRODUCTS/TECHNOLOGIES OFFERED
TABLE 180 RAPID LABS LTD: PRODUCTS OFFERED
TABLE 181 ORTHO CLINICAL DIAGNOSTICS: PRODUCTS OFFERED
TABLE 182 DIAGAST SAS: PRODUCTS/SERVICES OFFERED
TABLE 183 GRIFOLS SA: PRODUCTS/SERVICES OFFERED
TABLE 184 IMMUCOR, INC.: PRODUCTS/SERVICES OFFERED
TABLE 185 QUOTIENT LTD: PRODUCTS/SERVICES OFFERED
TABLE 186 QUOTIENT LTD: KEY DEVELOPMENTS
TABLE 187 YUVRAJ BIOBIZ INCUBATOR INDIA PVT LTD: PRODUCTS/SERVICES OFFERED
TABLE 188 TULIP DIAGNOSTICS: PRODUCTS/SERVICES OFFERED
TABLE 189 AIKANG: PRODUCTS/SERVICES OFFERED
TABLE 190 INTEC: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET STRUCTURE: GLOBAL BLOOD GROUPING REAGENTS MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL BLOOD GROUPING REAGENTS MARKET
FIGURE 5 DRIVERS: IMPACT ANALYSIS
FIGURE 6 RESTRAINT: IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN: GLOBAL BLOOD GROUPING REAGENTS MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BLOOD GROUPING REAGENTS MARKET
FIGURE 9 GLOBAL BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2020 & 2030 (USD MILLION)
FIGURE 10 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2020 & 2030 (USD MILLION)
FIGURE 11 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2020 & 2030 (USD MILLION)
FIGURE 12 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2020 & 2030 (USD MILLION)
FIGURE 13 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY REGION 2020 & 2030 (USD MILLION)
FIGURE 14 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY 2020 (%)
FIGURE 15 EUROPE: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 16 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 17 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY REGION, 2020
FIGURE 18 THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET
FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 20 REVENUE OF MAJOR PLAYERS, 2020
FIGURE 21 MAJOR PLAYERS R&D EXPENDITURE 2020
FIGURE 22 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MERCK KGAA: SWOT ANALYSIS
FIGURE 24 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 26 NOVACYT GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ORTHO CLINICAL DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 ORTHO CLINICAL DIAGNOSTICS: SWOT ANALYSIS
FIGURE 29 GRIFOLS SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 GRIFOLS SA: SWOT ANALYSIS
FIGURE 31 IMMUCOR, INC.: SWOT ANALYSIS
FIGURE 32 QUOTIENT LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 QUOTIENT LTD: SWOT ANALYSIS
